Cancers with IFN upregulation including GC, NPC, and DLBCL comprised one group, while EBV-associated cancers with a diminished IFN response when comparing EBV-positive and EBV-negative cancers including Burkitt lymphoma, angioimmunoblastic T cell lymphoma, NK/T cell lymphoma, and sporadic Burkitt lymphoma comprised the other group (171). This evidence concerns the gene IFNA1 and Burkitt lymphoma.